[{"indications": "Indications\u00a0\n(From Carbamazepine and related antiepileptics: British National Formulary)\nCarbamazepine and related antiepileptics", "name": "OXCARBAZEPINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.8 Antiepileptic drugs", "4.8.1 Control of the epilepsies", "Carbamazepine and related antiepileptics", "OXCARBAZEPINE"], "cautions": "Cautions\u00a0hypersensitivity to carbamazepine (see also Antiepileptic Hypersensitivity\r\nSyndrome); avoid abrupt withdrawal; hyponatraemia (monitor plasma-sodium concentration in patients at risk), heart failure (monitor body-weight), cardiac conduction disorders; avoid in acute\r\nporphyria (section 9.8.2); interactions: see Interactions in section\r\n4.8.1 and Appendix 1 (oxcarbazepine)Blood, hepatic, or skin disorders\u00a0Patients or their carers should be told how to recognise signs of\r\nblood, liver, or skin disorders, and advised to seek immediate medical\r\nattention if symptoms such as lethargy, confusion, muscular twitching,\r\nfever, rash, blistering, mouth ulcers, bruising, or bleeding develop", "side-effects": "Side-effects\u00a0nausea, vomiting, constipation, diarrhoea, abdominal\r\npain; dizziness, headache, drowsiness, agitation, amnesia, asthenia,\r\nataxia, confusion, impaired concentration, depression, tremor; hyponatraemia;\r\nacne, alopecia, rash, nystagmus, visual disorders including diplopia; less commonly urticaria, leucopenia; very rarely hepatitis, pancreatitis, arrhythmias, blood disorders, multi-organ\r\nhypersensitivity  (see also Antiepileptic Hypersensitivity\r\nSyndrome),\r\nsystemic lupus erythematosus, Stevens-Johnson syndrome, and toxic\r\nepidermal necrolysis; hypertension and hypothyroidism also reported;\r\nsuicidal ideation", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/201572.htm", "doses": ["Initially 300\u00a0mg twice daily increased according to response\r\nin steps of up to 600\u00a0mg daily at weekly intervals; usual dose range\r\n0.6\u20132.4\u00a0g daily in divided doses; child 6\u201318 years, 8\u201310\u00a0mg/kg daily in 2 divided doses increased according\r\nto response in steps of up to 10\u00a0mg/kg daily at weekly intervals (in\r\nadjunctive therapy, maintenance dose approx. 30\u00a0mg/kg daily); max.\r\n46\u00a0mg/kg daily in divided doses", "In adjunctive therapy, the dose\r\nof concomitant antiepileptics may need to be reduced when using high\r\ndoses of oxcarbazepine"], "pregnancy": "Pregnancy\u00a0see Pregnancy "}]